Xconomy: Agenda: Seattle Biotech Seizes the Momentum

Agenda: Seattle Biotech Seizes the Momentum


	5.6.2015	AGENDA
		.
	1:30 – 2:30	Registration & Networking
	2:30 – 2:40	Welcome & Opening Remarks Gary Gilliland, President & Director, Fred Hutchinson Cancer Research Center Jim Edwards, Publisher, Xconomy
	2:40 – 3:00	Fred Hutchinson Steps Towards Cures Gary Gilliland, Fred Hutchinson Cancer Research Center Alex Lash, National Biotech Editor, Xconomy
	3:00 – 3:30	Innovation’s Source: Seattle’s Nonprofit and Academic Core Gary Gilliland, Fred Hutchinson Cancer Research Center Charlotte Hubbert, Program Investment Officer, The Bill & Melinda Gates Foundation Vikram Jandhyala, Vice Provost for Innovation, CoMotion David Poston, COO, Allen Institute Alex Lash, National Biotech Editor, Xconomy (Moderator)
	3:30 – 3:50	T-Cell Therapies Hit The Clinic (Cancer Immunotherapy, Part 1) Hans Bishop, CEO, Juno Therapeutics Carlos Paya, CEO, Immune Design
	3:50 – 4:20	Local for the Long Haul: Building Seattle’s Anchor Biotechs Eric Dobmeier, COO, Seattle Genetics Heather Franklin, CEO, Blaze Bioscience Randy Schatzman, CEO, Alder Biotherapeutics Mike Gallatin, Senior Advisor, Frazier Healthcare (Moderator)
	4:20 – 4:45	Networking Break
	4:45 – 5:00	Adaptive Bulks Up (Cancer Immunotherapy, Part 2) Chad Robins, CEO, Adaptive Biotechnologies
	5:00 – 5:25	Square-Off: Biotech vs. Tech (But Also, Biotech + Tech) Robert Nelsen, Managing Director, ARCH Venture Partners Matt Mcllwain, Managing Director, Madrona Venture Group
	5:25 – 5:45	21st Century Wellness, and How to Get There Lee Hood, President, The Institute for Systems Biology Alex Lash, National Biotech Editor, Xconomy
	5:45 – 6:45	Networking Reception